Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Kiniksa Pharmaceuticals, Ltd. Financials Banner

Kiniksa Pharmaceuticals, Ltd. Financials

KNSA Stock Analysis

Page title

Section title

KNSA Income Statement Key Metrics

  • Revenue(TTM)338.93 M
  • Gross Profit(TTM)211.78 M
  • EBITDA(TTM)-26.37 M
  • Net Income(TTM)-10.23 M
  • EPS Diluted(TTM)-0.15500000000000003

Decode KNSA's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

KNSA earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of KNSA (0.663) is higher than the average of its peers (0.195).

Net Profit Margin vs Peers

Net profit margin ratio of KNSA (0.052) is higher than the average of its peers (-18.520).

KNSA Return on Equity

See how efficiently KNSA generates profit for it's shareholders.

3.21%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of KNSA (0.032) is higher than the average of its peers (-0.364).

Return on Equity Growth

KNSA's Return on Equity has shown poor growth over the past 10 years, increasing by only -34.36%.

KNSA Revenue Growth

See how KNSA has grown it's revenue over the past 10 years.


Revenue Growth

KNSA's revenue has grown significantly over the past 10 years, increasing by over 0%.

KNSA FY, 2023 Revenue Breakdown

See how KNSA converts it's revenue into profit.

KNSA Balance Sheet Health

KNSA Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

KNSA financial position analysis

Short Term Liabilities

KNSA's short term assets($276M) can safely cover it's short term liabilities($64M).

Long Term Liabilities

KNSA's short term assets($276M) can safely cover it's long term liabilities($24M).

KNSA Debt to Equity